Bio Spectra

Description

ATTITUDE® is a vegan toothpaste formulated with fluoride, designed for enamel care. It features a spearmint flavor and incorporates Super Leaves™ for enhanced natural care. The product is EWG Verified, ensuring adherence to strict safety and environmental standards. Each tube contains 120 g (4.2 oz) of the toothpaste, identified by NPN 80104880.

Uses and Indications

This drug is indicated for the prevention and treatment of dental caries, commonly known as cavities, and for the protection against tooth decay. It provides effective fluoride protection, which is essential in maintaining oral health.

Additionally, this drug protects teeth from acid erosion, a condition that can lead to significant dental issues. It is formulated to penetrate tooth enamel, aiding in the remineralization of weak spots, thereby enhancing the overall strength and integrity of the teeth.

Dosage and Administration

The product is intended for oral use only and should not be swallowed. It is recommended that the product be utilized as part of a comprehensive oral health program, which includes regular flossing and routine dental check-ups.

For adults and children over 6 years of age, the product should be applied by brushing the teeth thoroughly for a minimum of 1 minute, twice daily. This is preferably done after each meal or as directed by a dentist.

In children under 6 years of age, only a pea-sized amount of the product should be used. It is essential that children in this age group are supervised during brushing to ensure proper technique and to prevent swallowing of the product.

Healthcare professionals are advised to consult with a dentist or healthcare provider prior to recommending this product for use in children under 2 years of age.

Contraindications

There are no specific contraindications listed for this product. However, it is imperative to seek immediate medical assistance or contact a poison control center if the product is swallowed.

Warnings and Precautions

It is imperative to keep this medication out of reach of children to prevent accidental ingestion. In the event of swallowing the medication, immediate action is required. Healthcare professionals should advise patients or caregivers to contact a poison control center or seek medical assistance without delay.

Monitoring for potential adverse effects is essential to ensure patient safety. Regular assessments and appropriate laboratory tests may be necessary, depending on the specific medication and patient condition.

Side Effects

Patients should be advised to keep the product out of reach of children. In the event of accidental ingestion, it is crucial to contact a poison control center or seek medical assistance immediately.

No specific side effects or adverse reactions have been reported in clinical trials or postmarketing experiences.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Bio Spectra (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 6 years of age should use only a pea-sized amount of the product, and supervision is recommended to ensure proper brushing techniques and to prevent swallowing. For children under 2 years of age, it is advised to consult a dentist or healthcare professional prior to use.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information regarding the use of this drug during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment and the need to inform their healthcare provider if they become pregnant or plan to become pregnant while on this medication.

Lactation

There is no specific information available regarding the use of this drug in nursing mothers or any lactation considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to lactating mothers, as the effects on breastfed infants are not established. It is advisable to weigh the potential benefits against any unknown risks when considering treatment options for lactating patients.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate action is crucial. If the substance is ingested, it is imperative to contact a poison control center or seek medical assistance without delay.

Healthcare professionals should be aware that prompt intervention can significantly influence the outcome of an overdosage situation. Symptoms may vary depending on the specific substance involved, and it is essential to monitor the patient closely for any signs of toxicity.

Management procedures should include supportive care and symptomatic treatment as necessary. Continuous assessment of the patient's condition is recommended to address any complications that may arise.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to fully evaluate the nonclinical toxicology profile.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is important to emphasize that if the medication is swallowed, patients should immediately contact a poison control center or seek medical assistance without delay. This guidance is crucial for ensuring patient safety and minimizing potential risks associated with accidental ingestion.

Storage and Handling

The product is supplied in a tube format, with specific handling and storage requirements to ensure its integrity and effectiveness. It should be stored at room temperature, away from direct light exposure. To maintain the product's quality, it is essential to keep the tube tightly closed when not in use. Additionally, any unused product should be discarded after opening if it is not utilized within a specified time frame.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Bio Spectra, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)